Oncology Institute Inc Capital Reinvestment Ratio
Oncology Institute Inc capital reinvestment ratio. Oncology Institute Inc (TOI) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.23 Million) in capital expenditures ($1.06 Million). See TOI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oncology Institute Inc (2018–2020)
Capital reinvestment ratio of Oncology Institute Inc from 2018 to 2020. This chart tracks Oncology Institute Inc's Capital Reinvestment Ratio across 3 annual periods. See financial flexibility index of Oncology Institute Inc to measure the company's free cash flow as a share of total liabilities.
Oncology Institute Inc Capital Reinvestment Ratio by Year (2018–2020)
Oncology Institute Inc capital reinvestment ratio by year from 2018 to 2020. For the full cash flow conversion analysis, see Oncology Institute Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.35x | $508.00K | $1.19 Million | ▲ +605.4% |
| 2019 | 0.33x | $3.62 Million | $1.20 Million | ▲ +170.1% |
| 2018 | 0.12x | $5.64 Million | $695.96K | — |